These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
70 related articles for article (PubMed ID: 22917450)
21. The morning blood pressure surge and all-cause mortality in patients referred for ambulatory blood pressure monitoring. Israel S; Israel A; Ben-Dov IZ; Bursztyn M Am J Hypertens; 2011 Jul; 24(7):796-801. PubMed ID: 21490694 [TBL] [Abstract][Full Text] [Related]
22. Chronotherapy with valsartan/hydrochlorothiazide combination in essential hypertension: improved sleep-time blood pressure control with bedtime dosing. Hermida RC; Ayala DE; Mojón A; Fontao MJ; Fernández JR Chronobiol Int; 2011 Aug; 28(7):601-10. PubMed ID: 21823969 [TBL] [Abstract][Full Text] [Related]
24. Ambulatory 24-hour blood pressure monitoring: correlation between blood pressure variability and left ventricular hypertrophy in untreated hypertensive patients. Feola M; Boffano GM; Procopio M; Reynaud S; Allemano P; Rizzi G G Ital Cardiol; 1998 Jan; 28(1):38-44. PubMed ID: 9493044 [TBL] [Abstract][Full Text] [Related]
25. [Reduced nocturnal systolic blood pressure dip in obese children]. Ruiz Pons M; García Nieto V; García MG; García Mérida M; Valenzuela Hdez C; Aguirre-Jaime A Nefrologia; 2008; 28(5):517-24. PubMed ID: 18816210 [TBL] [Abstract][Full Text] [Related]
26. Influence of circadian time of hypertension treatment on cardiovascular risk: results of the MAPEC study. Hermida RC; Ayala DE; Mojón A; Fernández JR Chronobiol Int; 2010 Sep; 27(8):1629-51. PubMed ID: 20854139 [TBL] [Abstract][Full Text] [Related]
27. Analysis of factors that affect short-term blood pressure variability in patients with chronic renal failure. Sakai M; Tamura K; Tanaka Y; Tsurumi Y; Okano Y; Koide Y; Endoh T; Matsushita K; Kihara M; Hirawa N; Toya Y; Tokita Y; Ohnishi T; Umemura S Clin Exp Hypertens; 2005; 27(2-3):139-47. PubMed ID: 15835376 [TBL] [Abstract][Full Text] [Related]
28. Pulse pressure or dipping pattern: which one is a better cardiovascular risk marker in resistant hypertension? Muxfeldt ES; Salles GF J Hypertens; 2008 May; 26(5):878-84. PubMed ID: 18398329 [TBL] [Abstract][Full Text] [Related]
29. Reduced nocturnal blood pressure dip and sustained nighttime hypertension are specific markers of secondary hypertension. Seeman T; Palyzová D; Dusek J; Janda J J Pediatr; 2005 Sep; 147(3):366-71. PubMed ID: 16182677 [TBL] [Abstract][Full Text] [Related]
30. A comparison of the effects of fixed dose vs. single-agent combinations on 24-h blood pressure variability. Ulusoy S; Ozkan G; Konca C; Kaynar K Hypertens Res; 2012 Nov; 35(11):1111-7. PubMed ID: 22786565 [TBL] [Abstract][Full Text] [Related]
31. Comparison of ambulatory blood pressure parameters of hypertensive patients with and without chronic kidney disease. Mojón A; Ayala DE; Piñeiro L; Otero A; Crespo JJ; Moyá A; Bóveda J; de Lis JP; Fernández JR; Hermida RC; Chronobiol Int; 2013 Mar; 30(1-2):145-58. PubMed ID: 23181690 [TBL] [Abstract][Full Text] [Related]
32. A comparison of home measurement and ambulatory monitoring of blood pressure in the adjustment of antihypertensive treatment. Niiranen TJ; Kantola IM; Vesalainen R; Johansson J; Ruuska MJ Am J Hypertens; 2006 May; 19(5):468-74. PubMed ID: 16647616 [TBL] [Abstract][Full Text] [Related]
33. Sleep-time blood pressure: prognostic value and relevance as a therapeutic target for cardiovascular risk reduction. Hermida RC; Ayala DE; Fernández JR; Mojón A Chronobiol Int; 2013 Mar; 30(1-2):68-86. PubMed ID: 23181592 [TBL] [Abstract][Full Text] [Related]
34. Role of time-of-day of hypertension treatment on the J-shaped relationship between blood pressure and cardiovascular risk. Hermida RC; Ayala DE; Mojón A; Fernández JR Chronobiol Int; 2013 Mar; 30(1-2):328-39. PubMed ID: 23181738 [TBL] [Abstract][Full Text] [Related]
35. Chronotherapy with valsartan/amlodipine fixed combination: improved blood pressure control of essential hypertension with bedtime dosing. Hermida RC; Ayala DE; Fontao MJ; Mojón A; Fernández JR Chronobiol Int; 2010 Jul; 27(6):1287-303. PubMed ID: 20653455 [TBL] [Abstract][Full Text] [Related]
36. Association of heart rate with blood pressure variability: implications for blood pressure measurement. Cahan A; Ben-Dov IZ; Bursztyn M Am J Hypertens; 2012 Mar; 25(3):313-8. PubMed ID: 22158064 [TBL] [Abstract][Full Text] [Related]
37. Cardiovascular risk of resistant hypertension: dependence on treatment-time regimen of blood pressure-lowering medications. Ayala DE; Hermida RC; Mojón A; Fernández JR Chronobiol Int; 2013 Mar; 30(1-2):340-52. PubMed ID: 23077973 [TBL] [Abstract][Full Text] [Related]
38. Accuracy of twenty-four-hour ambulatory blood pressure monitoring (night-day values) for the diagnosis of secondary hypertension. Polonia J; Santos AR; Gama GM; Barros H J Hypertens; 1995 Dec; 13(12 Pt 2):1738-41. PubMed ID: 8903643 [TBL] [Abstract][Full Text] [Related]
39. Melatonin reduces night blood pressure in patients with nocturnal hypertension. Grossman E; Laudon M; Yalcin R; Zengil H; Peleg E; Sharabi Y; Kamari Y; Shen-Orr Z; Zisapel N Am J Med; 2006 Oct; 119(10):898-902. PubMed ID: 17000226 [TBL] [Abstract][Full Text] [Related]
40. Cardiovascular risk of essential hypertension: influence of class, number, and treatment-time regimen of hypertension medications. Hermida RC; Ayala DE; Mojón A; Fernández JR Chronobiol Int; 2013 Mar; 30(1-2):315-27. PubMed ID: 23181712 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]